Pharmaceutical
Ireland
Usa
Biopharmaceutical
Cardiovascular
Development
Commercializing
Restructuring
M&A Advisory
Lazard
Full Credential Description
Amarin. Ireland, United States. Announced Date 20/01/2017. Closed Date 13/02/2017. Deal value: $30m. Debt restructuring and related private placement of exchangeable senior notes. Industry: Amarin is a biopharmaceutical company focused on developing and commercializing therapeutics for cardiovascular health.